Brexpiprazole for treating agitation in different groups of people with Alzheimer’s dementia: a plain language summary

Jared Stroud, Jeffrey L. Cummings, Sanjeda R. Chumki, Pedro Such, David Wang, Anton M. Palma, Zhen Zhang, George T. Grossberg

Open source

DOI
10.1080/17582024.2026.2623968
Published
2026-02-14
Container
Neurodegenerative Disease Management
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17582024.2026.2623968,
  title = {Brexpiprazole for treating agitation in different groups of people with Alzheimer’s dementia: a plain language summary},
  author = {Jared Stroud and Jeffrey L. Cummings and Sanjeda R. Chumki and Pedro Such and David Wang and Anton M. Palma and Zhen Zhang and George T. Grossberg},
  year = {2026},
  journal = {Neurodegenerative Disease Management},
  doi = {10.1080/17582024.2026.2623968},
  url = {https://doi.org/10.1080/17582024.2026.2623968}
}

RIS

TY  - JOUR
TI  - Brexpiprazole for treating agitation in different groups of people with Alzheimer’s dementia: a plain language summary
AU  - Jared Stroud
AU  - Jeffrey L. Cummings
AU  - Sanjeda R. Chumki
AU  - Pedro Such
AU  - David Wang
AU  - Anton M. Palma
AU  - Zhen Zhang
AU  - George T. Grossberg
PY  - 2026
JO  - Neurodegenerative Disease Management
DO  - 10.1080/17582024.2026.2623968
UR  - https://doi.org/10.1080/17582024.2026.2623968
ER  - 

APA

Stroud, J., Cummings, J. L., Chumki, S. R., Such, P., Wang, D., Palma, A. M., Zhang, Z., & Grossberg, G. T. (2026). Brexpiprazole for treating agitation in different groups of people with Alzheimer’s dementia: a plain language summary. Neurodegenerative Disease Management. https://doi.org/10.1080/17582024.2026.2623968

Source records